» Articles » PMID: 28008315

Plant Protease Inhibitors in Therapeutics-Focus on Cancer Therapy

Overview
Journal Front Pharmacol
Date 2016 Dec 24
PMID 28008315
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

Plants are known to have many secondary metabolites and phytochemical compounds which are highly explored at biochemical and molecular genetics level and exploited enormously in the human health care sector. However, there are other less explored small molecular weight proteins, which inhibit proteases/proteinases. Plants are good sources of protease inhibitors (PIs) which protect them against diseases, insects, pests, and herbivores. In the past, proteinaceous PIs were considered primarily as protein-degrading enzymes. Nevertheless, this view has significantly changed and PIs are now treated as very important signaling molecules in many biological activities such as inflammation, apoptosis, blood clotting and hormone processing. In recent years, PIs have been examined extensively as therapeutic agents, primarily to deal with various human cancers. Interestingly, many plant-based PIs are also found to be effective against cardiovascular diseases, osteoporosis, inflammatory diseases and neurological disorders. Several plant PIs are under further evaluation in clinical trials. Among all types of PIs, Bowman-Birk inhibitors (BBI) have been studied extensively in the treatment of many diseases, especially in the field of cancer prevention. So far, crops such as beans, potatoes, barley, squash, millet, wheat, buckwheat, groundnut, chickpea, pigeonpea, corn, and pineapple have been identified as good sources of PIs. The PI content of such foods has a significant influence on human health disorders, particularly in the regions where people mostly depend on these kind of foods. These natural PIs vary in concentration, protease specificity, heat stability, and sometimes several PIs may be present in the same species or tissue. However, it is important to carry out individual studies to identify the potential effects of each PI on human health. PIs in plants make them incredible sources to determine novel PIs with specific pharmacological and therapeutic effects due to their peculiarity and superabundance.

Citing Articles

Analysis of Protein Inhibitors of Trypsin in Quinoa, Amaranth and Lupine Seeds. Selection and Deep Structure-Function Characterization of the Species.

Hernandez de la Torre M, Covaleda-Cortes G, Montesinos L, Covaleda D, Ortiz J, Pinol J Int J Mol Sci. 2025; 26(3).

PMID: 39940919 PMC: 11817793. DOI: 10.3390/ijms26031150.


The relationship between healthy eating index and Mediterranean diet adherence score with inflammatory indices and disease severity: a case-control study of hospitalized COVID-19 patients.

Mousavi R, Rostami S, Yazdi S, Kooshki A, Foroumandi E BMC Nutr. 2024; 10(1):168.

PMID: 39736713 PMC: 11686838. DOI: 10.1186/s40795-024-00983-2.


The Root-Tuber Trypsin Inhibitor of Winged Bean and Its Anti-cancerous Activity Against Osteosarcoma Cell-Line.

Lone R, Kumar B, Kashif M, Fakhrah S, Rout T, Siddiqui S Protein J. 2024; 44(1):88-101.

PMID: 39702856 DOI: 10.1007/s10930-024-10244-7.


Kunitz-type trypsin inhibitor from durian (Durio zibethinus) employs a distinct loop for trypsin inhibition.

Deetanya P, Limsardsanakij K, Sabat G, Pattaradilokrat S, Chaisuekul C, Wangkanont K Protein Sci. 2024; 33(12):e5230.

PMID: 39565068 PMC: 11577449. DOI: 10.1002/pro.5230.


Enhancing health and therapeutic potential: innovations in the medicinal and pharmaceutical properties of soy bioactive compounds.

Rahman U, Younas Z, Ahmad I, Yousaf T, Latif R, Rubab U Front Pharmacol. 2024; 15:1397872.

PMID: 39421675 PMC: 11483366. DOI: 10.3389/fphar.2024.1397872.


References
1.
Malkowicz S, McKenna W, Vaughn D, Wan X, Propert K, Rockwell K . Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia. Prostate. 2001; 48(1):16-28. DOI: 10.1002/pros.1077. View

2.
Caceres A, Cabrera O, Morales O, Mollinedo P, Mendia P . Pharmacological properties of Moringa oleifera. 1: Preliminary screening for antimicrobial activity. J Ethnopharmacol. 1991; 33(3):213-6. DOI: 10.1016/0378-8741(91)90078-r. View

3.
Sun J, Wang H, Ng T . Trypsin isoinhibitors with antiproliferative activity toward leukemia cells from Phaseolus vulgaris cv "White Cloud Bean". J Biomed Biotechnol. 2010; 2010:219793. PMC: 2896657. DOI: 10.1155/2010/219793. View

4.
Beliveau R, Gingras D . Role of nutrition in preventing cancer. Can Fam Physician. 2007; 53(11):1905-11. PMC: 2231485. View

5.
Clemente A, Arques M . Bowman-Birk inhibitors from legumes as colorectal chemopreventive agents. World J Gastroenterol. 2014; 20(30):10305-15. PMC: 4130838. DOI: 10.3748/wjg.v20.i30.10305. View